486 related articles for article (PubMed ID: 36029799)
41. Anticipatory Antifungal Treatment in Critically Ill Patients with SARS-CoV-2 Pneumonia.
Estella Á; Recuerda Núñez M; Lagares C; Gracia Romero M; Torres E; Alados Arboledas JC; Antón Escors Á; González García C; Sandar Núñez D; López Prieto D; Sánchez Calvo JM
J Fungi (Basel); 2023 Feb; 9(3):. PubMed ID: 36983456
[TBL] [Abstract][Full Text] [Related]
42. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P;
Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848
[TBL] [Abstract][Full Text] [Related]
43. Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19.
Sánchez Martín C; Madrid Martínez E; González Pellicer R; Armero Ibáñez R; Martínez González E; Llau Pitarch JV
Rev Esp Anestesiol Reanim (Engl Ed); 2022 Jan; 69(1):48-53. PubMed ID: 35033481
[TBL] [Abstract][Full Text] [Related]
44. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
[TBL] [Abstract][Full Text] [Related]
45. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
[TBL] [Abstract][Full Text] [Related]
46. Clinical characteristics, bacterial coinfections and outcomes in COVID-19-associated pulmonary aspergillosis in a third-level Mexican hospital during the COVID-19 pre-vaccination era.
Hernández-Silva G; Corzo-León DE; Becerril-Vargas E; Peralta-Prado AB; Odalis RG; Morales-Villarreal F; Ríos-Ayala MA; Alonso TG; Agustín FD; Ramón AF; Hugo AV
Mycoses; 2024 Jan; 67(1):e13693. PubMed ID: 38214372
[TBL] [Abstract][Full Text] [Related]
47. COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.
Meijer EFJ; Dofferhoff ASM; Hoiting O; Meis JF
Mycoses; 2021 Apr; 64(4):457-464. PubMed ID: 33569857
[TBL] [Abstract][Full Text] [Related]
48. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
[TBL] [Abstract][Full Text] [Related]
49. COVID-19-associated pulmonary aspergillosis: an underdiagnosed or overtreated infection?
Rouzé A; Martin-Loeches I; Nseir S
Curr Opin Crit Care; 2022 Oct; 28(5):470-479. PubMed ID: 35950729
[TBL] [Abstract][Full Text] [Related]
50. Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.
Vanderbeke L; Janssen NAF; Bergmans DCJJ; Bourgeois M; Buil JB; Debaveye Y; Depuydt P; Feys S; Hermans G; Hoiting O; van der Hoven B; Jacobs C; Lagrou K; Lemiale V; Lormans P; Maertens J; Meersseman P; Mégarbane B; Nseir S; van Oers JAH; Reynders M; Rijnders BJA; Schouten JA; Spriet I; Thevissen K; Thille AW; Van Daele R; van de Veerdonk FL; Verweij PE; Wilmer A; Brüggemann RJM; Wauters J;
Intensive Care Med; 2021 Jun; 47(6):674-686. PubMed ID: 34050768
[TBL] [Abstract][Full Text] [Related]
51. COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan.
Nasir N; Farooqi J; Mahmood SF; Jabeen K
Mycoses; 2020 Aug; 63(8):766-770. PubMed ID: 32585069
[TBL] [Abstract][Full Text] [Related]
52. Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study.
Bergmann F; Jorda A; Blaschke A; Gabler C; Bohdan S; Nussbaumer-Pröll A; Radtke C; Zeitlinger M
J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983483
[TBL] [Abstract][Full Text] [Related]
53. Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients.
Ergün M; Brüggemann RJM; Alanio A; Dellière S; van Arkel A; Bentvelsen RG; Rijpstra T; van der Sar-van der Brugge S; Lagrou K; Janssen NAF; Buil JB; van Dijk K; Melchers WJG; Reijers MHE; Schouten JA; Wauters J; Cordey A; Soni S; White PL; van de Veerdonk FL; Verweij PE
J Clin Microbiol; 2021 Nov; 59(12):e0122921. PubMed ID: 34495710
[TBL] [Abstract][Full Text] [Related]
54. Defining COVID-19-associated pulmonary aspergillosis: systematic review and meta-analysis.
Kariyawasam RM; Dingle TC; Kula BE; Vandermeer B; Sligl WI; Schwartz IS
Clin Microbiol Infect; 2022 Jul; 28(7):920-927. PubMed ID: 35150878
[TBL] [Abstract][Full Text] [Related]
55. COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients.
Calderón-Parra J; Mills-Sanchez P; Moreno-Torres V; Tejado-Bravo S; Romero-Sánchez I; Balandin-Moreno B; Calvo-Salvador M; Portero-Azorín F; García-Masedo S; Muñez-Rubio E; Ramos-Martinez A; Fernández-Cruz A;
Mycoses; 2022 May; 65(5):541-550. PubMed ID: 35212030
[TBL] [Abstract][Full Text] [Related]
56. Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy.
van Grootveld R; van der Beek MT; Janssen NAF; Ergün M; van Dijk K; Bethlehem C; Stads S; van Paassen J; Heunks LMA; Bouman CSC; Reijers MHE; Brüggeman RJ; van de Veerdonk FL; van Bree SHW; van den Berg CHSB; Kuindersma M; Wauters J; Beishuizen A; Verweij PE; Schouten JA;
J Crit Care; 2023 Aug; 76():154272. PubMed ID: 36801598
[TBL] [Abstract][Full Text] [Related]
57. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G
Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087
[TBL] [Abstract][Full Text] [Related]
58. Clinical characteristics of patients with coronavirus disease 2019-associated pulmonary aspergillosis on mechanical ventilation: A single-center retrospective study in Japan.
Ogawa Y; Murata K; Hasegawa K; Nishida K; Gohma I; Kasahara K
J Infect Chemother; 2023 Mar; 29(3):239-243. PubMed ID: 36379404
[TBL] [Abstract][Full Text] [Related]
59. Dysregulated pulmonary inflammatory responses exacerbate the outcome of secondary aspergillosis following influenza.
Lee CK; Oliveira LVN; Akalin A; Specht CA; Lourenco D; Gomez CL; Ramirez-Ortiz ZG; Wang JP; Levitz SM
mBio; 2023 Oct; 14(5):e0163323. PubMed ID: 37681974
[TBL] [Abstract][Full Text] [Related]
60. A Pathology-based Case Series of Influenza- and COVID-19-associated Pulmonary Aspergillosis: The Proof Is in the Tissue.
Vanderbeke L; Jacobs C; Feys S; Reséndiz-Sharpe A; Debaveye Y; Hermans G; Humblet-Baron S; Lagrou K; Meersseman P; Peetermans M; Seldeslachts L; Vanstapel A; Vande Velde G; Van Wijngaerden E; Wilmer A; Verbeken E; De Hertogh G; Wauters J
Am J Respir Crit Care Med; 2023 Aug; 208(3):301-311. PubMed ID: 37311243
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
